Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

±Þ¼º°ñ¼ö¼º¹éÇ÷º´ ȯÀÚÀÇ °ø°í¿ä¹ý¿¡¼­ CytarabineÀÇ ¿ë·®ÀÌ ¿¹ÈÄ¿¡ ¹ÌÄ¡´Â ¿µÇâ Prognostic Implications of Cytarabine Dose in Consolidation Chemotherapy for the Patients with Acute Myelogenous Leukemia

´ëÇѾÏÇÐȸÁö 2000³â 32±Ç 5È£ p.954 ~ 961
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÁ¤Èñ/Jung-Hee Lee ÀÌÁ¦È¯/À̱ÔÇü/¹æÇý½Â/¾ÈÁøÈñ/ÀÌÁ¤½Å/±è»óÈñ/±è¿ì°Ç/Je-Hwan Lee/Kyoo-Hyung Lee/Hyeseung Bahng/Jin-Hee Ahn/Jung-Shin Lee/Sang-Hee Kim/Woo-Kun Kim

Abstract

[ÃʷϾøÀ½:No abstract]

Å°¿öµå

Cytarabine; Dose; Consolidation chemotherapy; Acute myelogenous leukemia;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS